In contrast, Novos ads for Wegovy and Ozempic were upbeat, aspirational and rooted in personal transformation
Every week, I sit down with elite researchers, doctors, and high-performers to cut through the noise and hand you biological leverage most people will never have access to
The interaction theory assumes the formation of chemical bonds between water and the hydrophilic groups within the polymer network 29,30
I know what it takes to be the best
Cash-pay telehealth weight loss was the early model (companies like Ro, Hims, Calibrate): Monthly membership fee ($50-200) Plus cost of medication (either marked up through compounding pharmacies or retail GLP-1s) Patients pay out of pocket entirely Pros: No insurance billing hassle Higher margins per patient if you mark up medications Cons: Limited to affluent patients High churn when patients cant afford $300-500/month ongoing Regulatory scrutiny (many compounded semaglutide products were investigated for safety) Insurance-based model is becoming more viable: Bill insurance for visits (E/M codes) Send GLP-1 prescription to patients pharmacy (they use insurance for medication) You get paid per visit (~$100-150), patient pays copay Pros: Larger addressable market (anyone with obesity diagnosis and insurance) More sustainable (patients can afford to stay on therapy long-term) Less regulatory risk (using FDA-approved products through licensed pharmacies) Cons: Prior authorization burden Payment delays from insurers Need credentialing with multiple payers Hybrid approach: Some practices bill insurance when possible, offer cash-pay as backup for patients with exclusions
As more research is conductedthe very research that our clients are undertaking with compounds like BPC-157, TB-500 Thymosin Beta 4, and the broader array of molecules in our full peptide collectionthe body of evidence will grow
